Recon Onkos Surgical® Announces Initiation of 522 Post-Market Surveillance Study of the ELEOS™ Limb Salvage System with NanoCept® Antibacterial Implant Technology byTim AllenFebruary 12, 2026
Biologics Spine BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease byTim AllenFebruary 10, 2026
Spine Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data byTim AllenJanuary 7, 2026
Biologics Extremities Top Stories Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion byWill SandbergDecember 2, 2025
Sports Medicine NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain byJosh SandbergOctober 13, 2025
Spine First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial byTim AllenSeptember 25, 2025
Biologics Spine Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration byJosh SandbergJuly 29, 2025
Recon BEAR MOON Study of Miach Orthopaedics’ BEAR® Implant Completes Enrollment byTim AllenJuly 7, 2025
Extremities Top Stories Alafair Biosciences Announces First Patient Enrolled in Multi-Center Study Evaluating VersaWrap® Tendon Protector for Achilles Repair byBree MillerJune 25, 2025
